Form 4: MKS Director Sells Shares Under 10b5-1 Plan
Insider Transaction
MKS Inc. Director Jacqueline F. Moloney sold 300 shares of common stock for $122.14 per share on October 1, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Jacqueline F. Moloney, a Director of MKS Inc. (MKSI), reported a sale of common stock.
- The transaction involved the disposition of 300 shares of MKS Inc. common stock.
- The shares were sold at a price of $122.14 per share.
- The transaction date was October 1, 2025.
- Following this transaction, Moloney beneficially owns 11,562.304 shares of MKS Inc. common stock.
- This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Moloney on September 10, 2024.
Sentiment
Score: 5
Explanation: The transaction is a routine sale of shares by a director under a pre-arranged Rule 10b5-1 trading plan, which typically does not indicate a change in company fundamentals or management's outlook.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
This is a specific insider transaction and does not provide information related to broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | Jacqueline F. Moloney's sale was executed under a Rule 10b5-1 trading plan adopted on September 10, 2024, demonstrating adherence to insider trading regulations. | 2024-09-10 | Rule 10b5-1 plans are a common corporate governance practice to allow insiders to sell shares without concerns of trading on material non-public information, enhancing transparency and reducing potential for perceived conflicts of interest. |
Stakeholder Impact
- Shareholders: Minimal impact. A routine, pre-scheduled sale by a director under a 10b5-1 plan is generally not interpreted as a signal of negative company performance and typically does not significantly affect shareholder sentiment or share price.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.
Key Dates
| Date | Description |
|---|---|
| 2024-09-10 | Rule 10b5-1 trading plan adopted by Jacqueline F. Moloney. |
| 2025-10-01 | Transaction date for the sale of 300 shares of common stock. |
| 2025-10-02 | Date of filing of the Form 4 statement. |
Recommendation
holdThis Form 4 filing reports a routine, pre-scheduled sale of a relatively small number of shares by a director under a Rule 10b5-1 trading plan. Such transactions are typically not indicative of changes in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation. Investors should continue to hold based on their existing analysis of MKS Inc.'s fundamentals.
Keywords
MKS Inc., MKSI, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Director, Jacqueline F Moloney, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.